Extendicare (TSE:EXE) PT Set at C$15.40 by National Bankshares

Extendicare (TSE:EXEGet Free Report) received a C$15.40 price objective from equities researchers at National Bankshares in a note issued to investors on Thursday,BayStreet.CA reports. The firm currently has an “outperform” rating on the stock. National Bankshares’ price target points to a potential upside of 19.29% from the stock’s previous close.

Other equities analysts have also recently issued research reports about the company. BMO Capital Markets raised their price target on Extendicare from C$13.50 to C$14.50 in a report on Monday, May 12th. TD Securities raised their target price on shares of Extendicare from C$13.00 to C$15.00 and gave the company a “hold” rating in a report on Thursday, May 22nd. Three investment analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of C$13.98.

View Our Latest Analysis on Extendicare

Extendicare Trading Down 2.4%

Shares of Extendicare stock opened at C$12.91 on Thursday. Extendicare has a twelve month low of C$7.34 and a twelve month high of C$15.24. The company has a quick ratio of 0.98, a current ratio of 0.62 and a debt-to-equity ratio of 283.02. The business has a 50-day moving average price of C$14.03 and a 200-day moving average price of C$12.76. The firm has a market cap of C$1.08 billion, a price-to-earnings ratio of 16.46 and a beta of 1.26.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Further Reading

Analyst Recommendations for Extendicare (TSE:EXE)

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.